×
Aktivieren Sie Javascript in Ihrem Browser, um unsere Webseite optimal zu nutzen.
EIF4G2 Antikörper (AA 1-204)
EIF4G2
Reaktivität: Human
WB, IHC
Wirt: Kaninchen
Polyclonal
unconjugated
Produktnummer ABIN1885765
Produktdetails anti-EIF4G2 Antikörper
(ausblenden)
Target
Alle EIF4G2 Antikörper anzeigen
EIF4G2
(Eukaryotic Translation Initiation Factor 4 gamma 2 (EIF4G2))
Bindungsspezifität
Alle Epitope für EIF4G2 Antikörper
AA 1-204
Reaktivität
Alle Reaktivitäten für EIF4G2 Antikörper
Human
Wirt
Alle Wirte für EIF4G2 Antikörper
Kaninchen
Klonalität
Alle Klonalitäten für EIF4G2 Antikörper
Polyklonal
Konjugat
Alle Konjugate für EIF4G2 Antikörper
Dieser EIF4G2 Antikörper ist unkonjugiert
Applikation
Alle Applikationen für EIF4G2 Antikörper
Western Blotting (WB), Immunohistochemistry (IHC)
Aufreinigung
Purified by antigen-affinity chromatography.
Immunogen
Recombinant protein fragment contain a sequence corresponding to a region within amino acids 1 and 204 of Human EIF4G2
Top Product
Discover our top product EIF4G2 Primärantikörper
Alternativen
(anzeigen)
Anwendungsinformationen
(ausblenden)
Applikationshinweise
Suggested dilutions: Western blotting: 1.500-1.3000 Immunohistochemistry: 1.100-1.250
Beschränkungen
Nur für Forschungszwecke einsetzbar
Handhabung
(ausblenden)
Format
Liquid
Buffer
0.1 M Tris-buffered saline with 10 % Glycerol (pH 7.0).0.01 % Thimerosal was added as a preservative.
Konservierungsmittel
Thimerosal (Merthiolate)
Vorsichtsmaßnahmen
Biohazard Informations: This product contains thimerosal which is hazardous.
Lagerung
4 °C/-20 °C
Informationen zur Lagerung
Store at -20 °C for long term preservation (recommended). Store at 4 °C for short term use.
Details zu EIF4G2
(ausblenden)
Target
EIF4G2
(Eukaryotic Translation Initiation Factor 4 gamma 2 (EIF4G2))
Andere Bezeichnung
DAP5 (EIF4G2 Produkte )
Synonyme
AAG1 antikoerper, DAP5 antikoerper, NAT1 antikoerper, P97 antikoerper, NAT1B antikoerper, eif4g2 antikoerper, hm:zeh1307 antikoerper, wu:fa14h01 antikoerper, wu:fb44h01 antikoerper, wu:fb59c06 antikoerper, wu:fc21b05 antikoerper, EIF4G2 antikoerper, AA589388 antikoerper, DAP-5 antikoerper, E130105L11Rik antikoerper, Nat1 antikoerper, Natm1 antikoerper, p97 antikoerper, NAT1A antikoerper, im:7148615 antikoerper, wu:fb81f07 antikoerper, wu:fb82b06 antikoerper, wu:fb98h08 antikoerper, dap5 antikoerper, eif4g2.L antikoerper, nat1 antikoerper, eukaryotic translation initiation factor 4 gamma 2 antikoerper, eukaryotic translation initiation factor 4, gamma 2b antikoerper, eukaryotic translation initiation factor 4, gamma 2 antikoerper, eukaryotic translation initiation factor 4 gamma, 2 antikoerper, eIF4G-related protein NAT1 antikoerper, eukaryotic translation initiation factor 4, gamma 2a antikoerper, eukaryotic translation initiation factor 4 gamma, 2 S homeolog antikoerper, EIF4G2 antikoerper, eif4g2b antikoerper, Eif4g2 antikoerper, nat1 antikoerper, eif4g2a antikoerper, eif4g2.S antikoerper
Hintergrund
Translation initiation is mediated by specific recognition of the cap structure by eukaryotic translation initiation factor 4F (eIF4F), which is a cap binding protein complex that consists of three subunits: eIF4A, eIF4E and eIF4G.The protein encoded by this gene shares similarity with the C-terminal region of eIF4G that contains the binding sites for eIF4A and eIF3, eIF4G, in addition, contains a binding site for eIF4E at the N-terminus.Unlike eIF4G, which supports cap-dependent and independent translation, this gene product functions as a general repressor of translation by forming translationally inactive complexes.In vitro and in vivo studies indicate that translation of this mRNA initiates exclusively at a non-AUG (GUG) codon.Alternatively spliced transcript variants encoding different isoforms of this gene have been described.[provided by RefSeq]
Molekulargewicht
102 kDa
Gen-ID
1982
NCBI Accession
NP_001409 , NM_001418
Zuletzt angesehen
(ausblenden)